Fundz

Cardiosense Appoints John Martin, MD as Chief Medical Officer

PRIVATEAug 12, 2025

Position

Vice President

Company

Cardiosense

John Martin
ChicagoHealth Care

Description

Cardiosense has announced the appointment of John Martin, MD, MBA, as Executive Vice President and Chief Medical Officer. Martin, a veteran medtech leader and vascular surgeon, will guide the company's clinical development and product strategy during a transformative phase.

Quick answer

Cardiosense Appoints John Martin, MD as Chief Medical Officer (August 12, 2025). Cardiosense is based in Chicago, Illinois, United States.

Who is the new Vice President at Cardiosense?
Cardiosense named John Martin Vice President, announced August 12, 2025.
What did Cardiosense announce on August 12, 2025?
Cardiosense has announced the appointment of John Martin, MD, MBA, as Executive Vice President and Chief Medical Officer. Martin, a veteran medtech leader and vascular surgeon, will guide the company's clinical development and product strategy during a transformative phase.
What does Cardiosense do?
Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease.
Where is Cardiosense based?
Cardiosense is based in Chicago, Illinois, United States.

Source: Fundz verified event record.

Who to call at Cardiosense, and when

A new leader at Cardiosense brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cardiosense raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cardiosense, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cardiosense. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cardiosense

Location

400 N. Aberdeen St.

Chicago, Illinois, United States

About

Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease. The Company has developed a suite of novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease, inform personalized therapy, and improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cardiosense changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Cardiosense's next move

Learn about Strategic plan

Cardiosense changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.